SPHERA FUNDS MANAGEMENT LTD. - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 37 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2018. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2018$7,844,000
-36.0%
980,5020.0%1.08%
-41.9%
Q1 2018$12,256,000–980,502–1.86%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q2 2018.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders